Globus Medical (GMED) P/E ratio
Globus Medical (GMED) trades at 17.2× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 22.3×. That is 79.8% lower than the 110.3× of fiscal 2024. Figures as of 18 Nov 2026, 11:42 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/E ratio today
- 17.2×
- P/E ratio, fiscal 2025
- 22.3×
- Change on fiscal 2024
- −79.8%
- Highest on record
- 110.3×fiscal 2024
- Lowest on record
- 13.1×fiscal 2012
- Fiscal years on record
- 142012–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Globus Medical P/E ratio, in more detail
Today's figure is 22.6% below the fiscal 2025 year-end.
Across the 14 fiscal year-ends on record (2012–2025), the highest was 110.3× in fiscal 2024 and the lowest 13.1× in fiscal 2012. Today's P/E ratio is higher than at 7% of the 14 fiscal year-ends on record; their median is 32.7×.
P/E ratio at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Globus Medical P/E ratio, year by year
| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
|---|---|---|---|---|---|
| Today | 17.2× | — | $69.99 | — | |
| 2025 | 22.3× | 79.8% down | $87.31 | $3.92 | |
| 2024 | 110.3× | 121.4% up | $82.71 | $0.75 | |
| 2023 | 49.8× | 24.1% up | $53.29 | $1.07 | |
| 2022 | 40.1× | 19.9% down | $74.27 | $1.85 | |
| 2021 | 50.1× | 22.4% down | $72.20 | $1.44 | |
| 2020 | 64.6× | 66.7% up | $65.22 | $1.01 | |
| 2019 | 38.7× | 37.8% up | $58.88 | $1.52 | |
| 2018 | 28.1× | 24.8% down | $43.28 | $1.54 | |
| 2017 | 37.4× | 62.6% up | $41.10 | $1.10 | |
| 2016 | 23.0× | 3.4% down | $24.81 | $1.08 | |
| 2015 | 23.8× | 3.0% down | $27.82 | $1.17 | |
| 2014 | 24.5× | 11.4% down | $23.77 | $0.97 | |
| 2013 | 27.6× | 110.8% up | $20.18 | $0.73 | |
| 2012 | 13.1× | — | $10.49 | $0.80 | |
| 2011 | — | — | — | $0.67 | |
| 2010 | — | — | — | $0.60 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
How to read it
It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.
P/E ratio at health care companies of similar size
| Company | P/E ratio |
|---|---|
| Qiagen QGEN | 26.9× |
| Insulet PODD | 23.7× |
| Globus Medical GMED | 17.2× |
Price over the last twelve months' earnings per share, as the market data feed reports it.
Globus Medical, figure by figure
- Globus Medical market cap
- Globus Medical revenue
- Globus Medical earnings
- Globus Medical earnings per share (EPS)
- Globus Medical P/S ratio
- Globus Medical P/B ratio
- Globus Medical free cash flow
- Globus Medical operating margin
- Globus Medical dividend
- Globus Medical shares outstanding
- Globus Medical total debt
- Globus Medical cash on hand
- Globus Medical total assets
- Globus Medical return on equity (ROE)
- Globus Medical return on invested capital (ROIC)
Globus Medical (GMED) overview: price, valuation and scorecardAll health care companies by market value
Globus Medical P/E ratio: questions and answers
What is Globus Medical's P/E ratio?
Globus Medical (GMED) trades at 17.2× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 22.3×. That is 79.8% lower than the 110.3× of fiscal 2024.
Is Globus Medical's P/E ratio high or low compared with its own history?
Today's P/E ratio is higher than at 7% of the 14 fiscal year-ends on record; their median is 32.7×.
What are the highest and lowest P/E ratio figures on record for Globus Medical?
Across the 14 fiscal year-ends on record (2012–2025), the highest was 110.3× in fiscal 2024 and the lowest 13.1× in fiscal 2012.
How is Globus Medical's P/E ratio calculated?
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Globus Medical it is on record here for 14 fiscal years, 2012 to 2025.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/E ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Globus Medical (GMED) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/GMED/pe-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.